Pantai Premier Pathology hosted over 220 participants from diverse public and private healthcare backgrounds to a Molecular Infectious Diseases Symposium on 4 August.
Themed Navigating the Future of Infectious Diseases, the symposium was a platform to discuss current and future patterns in infectious diseases as well as the practicality of modern molecular technologies to aid clinicians in their patient management.
The symposium was officiated by Yang Berbahagia Datuk Dr Christopher Lee, Deputy Director General of Health (Research & Technical Support), Ministry of Health Malaysia. Speakers at the symposium were experts from various healthcare institutions.
Through this symposium, we hope to gather experts from across clinical, research and healthcare industries so that we can work in synergy to find effective approaches to infectious diseases.
- Hareeff Muhammed, Chief Executive Officer, Pantai Premier Pathology
Related Stories
Project Renaissance at Mount Elizabeth Hospital, Where Legacy Meets the Future of Care
Over a span of 1,095 days, Project Renaissance marked a significant chapter in the evolution of Mount Elizabeth Hospital, one of Singapore’s most established private healthcare institutions. Conceived as a strategic transformation rather than a conventional refurbishment, the initiative sought to position the hospital for the demands of a rapidly changing healthcare landscape.
IHH Healthcare North Asia Strengthens Integrated Care Through Strategic Partnership
2026 IHH Global Town Hall: Building a Future-ready Workforce
'Building a Future-ready Workforce' took centre stage at IHH Healthcare's 2026 Global Town Hall on 9 February, bringing colleagues together across 10 countries in a truly hybrid experience that underscored the group's commitment to future-proof healthcare.
IHH Malaysia Partners Libyan Government for Medical Referrals
IHH Healthcare Malaysia signed a Memorandum of Understanding (MOU) with The Government of Libya on 9 February, establishing a structured medical referral pathway for Libyan civil servants requiring specialist treatment at 18 hospitals across IHH’s Malaysian network.
Agilus Diagnostics Expands Access to Next-Generation Precision Genomics
Agilus Diagnostics, a subsidiary of Fortis Healthcare, has installed the Illumina NovaSeq X sequencing platform at its Mumbai reference laboratory, marking a major step forward for precision genomics in India.
